Clinical Trial Update: Low-dose GH Supplementation Increases Clinical Pregnancy Rate [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial suggests that low-dose growth hormone supplementation may increase clinical pregnancy rates in infertile individuals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Growth Hormone (somatropin)

Snippet

Sponsor: Centro de Infertilidad y Reproducción Humana | Conditions: Infertility | Phase 1 | Status: COMPLETED